Innate Pharma S.A.
- IPHA
- NASDAQ
- Biotechnology
- Oncology Antibodies
- Biotech (Therapeutic Antibodies)
$1.46
Today +2.10%Quote Oct 19, 2026, 08:00 PM UTC
−23.16%over the last month
Max drawdown −24.7%From 1-month high −23.2%3 months −17.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Innate Pharma
Innate Pharma S.A. is a biotechnology firm, founded in 1999 and headquartered in Marseille, France, that specializes in the discovery, development, and market introduction of therapeutic antibodies. The company primarily targets oncology indications across France and internationally, with some programs also addressing inflammatory diseases and viral infections.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
163
Founded
1999
Market value
$136.8M
Quote Oct 19
Floor
$1.41
3.4% below price
Resistance
$1.48
1.1% above price
Price vs analyst targets
6 analysts
Lowest target
$4.00Highest target
$9.00
$4.00Highest target
$9.00
- Price $1.46
- Average target $6.67
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 357% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about IPHAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free